December 28th, 2021
•Patient-derived organoids (PDOs) are a powerful tool in translational cancer research, reflecting both the genetic and phenotypic heterogeneity of the disease and response to personalized anti-cancer therapies. Here, a consolidated protocol to generate human primary bladder cancer PDOs in preparation for the evaluation of phenotypic analyses and drug responses is detailed.
Related Videos
A Murine Orthotopic Bladder Tumor Model and Tumor Detection System
3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer
Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses
Culture, Manipulation, and Orthotopic Transplantation of Mouse Bladder Tumor Organoids
Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids
Establishment and Culture of Patient-Derived Breast Organoids
Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids (Video) | JoVE
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved